2023 Q2 Form 10-Q Financial Statement

#000147793223005693 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q2
Revenue $588.5K
YoY Change 8.76%
Cost Of Revenue $307.7K
YoY Change -12.77%
Gross Profit $280.8K
YoY Change 49.07%
Gross Profit Margin 47.71%
Selling, General & Admin $258.7K
YoY Change 37.42%
% of Gross Profit 92.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $258.7K
YoY Change 37.42%
Operating Profit $22.09K
YoY Change 19445.13%
Interest Expense $3.256K
YoY Change
% of Operating Profit 14.74%
Other Income/Expense, Net -$3.256K
YoY Change 10.75%
Pretax Income $18.83K
YoY Change -766.08%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $18.83K
YoY Change -766.08%
Net Earnings / Revenue 3.2%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 16.56M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.06K
YoY Change 839.95%
Cash & Equivalents $35.06K
Short-Term Investments
Other Short-Term Assets $74.76K
YoY Change 75.62%
Inventory $279.3K
Prepaid Expenses $43.15K
Receivables $148.1K
Other Receivables $0.00
Total Short-Term Assets $537.1K
YoY Change -0.87%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $537.1K
Total Long-Term Assets $0.00
Total Assets $537.1K
YoY Change -0.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $75.72K
YoY Change -34.82%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $290.0K
YoY Change 28.89%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $365.7K
YoY Change 7.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $365.7K
Total Long-Term Liabilities $0.00
Total Liabilities $365.7K
YoY Change 7.2%
SHAREHOLDERS EQUITY
Retained Earnings -$23.61M
YoY Change 0.33%
Common Stock $23.78M
YoY Change 0.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $171.4K
YoY Change
Total Liabilities & Shareholders Equity $537.1K
YoY Change -0.87%

Cashflow Statement

Concept 2023 Q2
OPERATING ACTIVITIES
Net Income $18.83K
YoY Change -766.08%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$22.58K
YoY Change -56.97%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 17.00K
YoY Change -46.05%
NET CHANGE
Cash From Operating Activities -22.58K
Cash From Investing Activities
Cash From Financing Activities 17.00K
Net Change In Cash -5.580K
YoY Change -73.38%
FREE CASH FLOW
Cash From Operating Activities -$22.58K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001414953
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16327596 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16230615 shares
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55269
dei Entity Registrant Name
EntityRegistrantName
EQUATOR Beverage Company
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0884348
dei Entity Address Address Line1
EntityAddressAddressLine1
185 Hudson Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Floor 25
dei Entity Address City Or Town
EntityAddressCityOrTown
Jersey City
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07302
dei City Area Code
CityAreaCode
929
dei Local Phone Number
LocalPhoneNumber
264-7944
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16327596 shares
CY2023Q2 us-gaap Security Deposit
SecurityDeposit
113 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
113 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
537130 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
441119 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
75723 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
70252 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
290000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
225000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
365723 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
295252 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
16231 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
23758917 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23629281 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
145867 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
441119 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
588478 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
541102 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
352759 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
280757 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
188343 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
188230 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
258671 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
188230 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
22086 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3256 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2940 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18830 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2827 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16557928 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15810725 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1104113 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
920759 usd
us-gaap Cost Of Revenue
CostOfRevenue
621179 usd
us-gaap Cost Of Revenue
CostOfRevenue
585343 usd
us-gaap Gross Profit
GrossProfit
482934 usd
us-gaap Gross Profit
GrossProfit
335416 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
453583 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
469796 usd
us-gaap Operating Expenses
OperatingExpenses
453583 usd
us-gaap Operating Expenses
OperatingExpenses
469796 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
29351 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-134380 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6036 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3826 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23315 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-138206 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13344 usd
us-gaap Net Income Loss
NetIncomeLoss
9971 usd
us-gaap Net Income Loss
NetIncomeLoss
-138206 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16881644 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15658344 shares
us-gaap Profit Loss
ProfitLoss
23315 usd
us-gaap Profit Loss
ProfitLoss
-138206 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
40227 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
136073 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-54204 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-58105 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10963 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-94245 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
13272 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-19790 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2754 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5470 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
57221 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2673 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-100016 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
170000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
352000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
105000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
127000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25448 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
38002 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
193188 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26998 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
57260 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24325 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42756 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10738 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46481 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35063 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3725 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
145867 usd
CY2023Q1 mojo Stock Issued To Directors And Employees Amount
StockIssuedToDirectorsAndEmployeesAmount
13992 usd
CY2023Q1 mojo Stock Repurchased And Returned To Treasury
StockRepurchasedAndReturnedToTreasury
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4485 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
164344 usd
CY2023Q2 mojo Stock Issued To Directors And Employees Amount
StockIssuedToDirectorsAndEmployeesAmount
26235 usd
CY2023Q2 mojo Stock Repurchased And Returned To Treasury Amount
StockRepurchasedAndReturnedToTreasuryAmount
-38002 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
18830 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
171407 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
370553 usd
CY2022Q1 mojo Stock Issued To Directors And Employees Amount
StockIssuedToDirectorsAndEmployeesAmount
112005 usd
CY2022Q1 mojo Stock Repurchased And Returned To Treasury Amount
StockRepurchasedAndReturnedToTreasuryAmount
-101250 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-135379 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
245929 usd
CY2022Q2 mojo Stock Issued To Directors And Employees Amount
StockIssuedToDirectorsAndEmployeesAmount
24068 usd
CY2022Q2 mojo Exercise Of Stock Options Amount
ExerciseOfStockOptionsAmount
25448 usd
CY2022Q2 mojo Stock Repurchased And Returned To Treasury Amount
StockRepurchasedAndReturnedToTreasuryAmount
-91938 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2827 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
200680 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1122047 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1124666 usd
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7480316 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7497770 usd
CY2023Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
380019 shares
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
38002 usd

Files In Submission

Name View Source Status
0001477932-23-005693-index-headers.html Edgar Link pending
0001477932-23-005693-index.html Edgar Link pending
0001477932-23-005693.txt Edgar Link pending
0001477932-23-005693-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mojo-20230630.xsd Edgar Link pending
mojo_10q.htm Edgar Link pending
mojo_ex311.htm Edgar Link pending
mojo_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mojo-20230630_def.xml Edgar Link unprocessable
mojo-20230630_lab.xml Edgar Link unprocessable
mojo-20230630_pre.xml Edgar Link unprocessable
mojo_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
mojo-20230630_cal.xml Edgar Link unprocessable